Advertisement

European Journal of Dermatology

, Volume 26, Issue 4, pp 390–391 | Cite as

Autoantibody serum levels and intensity of pruritus in bullous pemphigoid

  • Federico Bardazzi
  • Alessia Barisani
  • Michela Magnano
  • Vera Tengattini
  • Michelangelo La Placa
  • Annalisa Patrizi
  • Riccardo Balestri
Correspondence
  • 22 Downloads

References

  1. 1.
    Lee EH, Kim YH, Kim S, Kim SE, Kim SC. Usefulness of enzymelinked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid. Ann Dermatol 2012; 24: 45–55.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kobayashi M, Amagai M, Kuroda-Kinoshita K, et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30: 224–32.CrossRefGoogle Scholar
  3. 3.
    Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid. Clin Dev Immunol 2012; 2012: 854795.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Feng S,Wu Q, Jin P, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Int J Dermatol 2008; 47: 225–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Tsuji-Abe Y, Akiyama M, Yamanaka Y, Kikuchi T, Sato-Matsumura KC, Shimizu H. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid. J Dermatol Sci 2005; 37: 145–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Amo Y, Ohkawa T, Tatsuta M, et al. Clinical significance of enzymelinked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Dermatol Sci 2001; 26: 14–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Hofmann S, Thoma-Uszynski S, Hunziker T, et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119: 1065–73.CrossRefPubMedGoogle Scholar
  9. 9.
    Reich A, Heisig M, Phan NQ, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497–501.CrossRefPubMedGoogle Scholar
  10. 10.
    Du-Thahn A, Merlet S, Maillard H, et al. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study. Br J Dermatol 2011; 165: 1337–43.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2016

Authors and Affiliations

  • Federico Bardazzi
    • 1
  • Alessia Barisani
    • 1
  • Michela Magnano
    • 1
  • Vera Tengattini
    • 1
  • Michelangelo La Placa
    • 1
  • Annalisa Patrizi
    • 1
  • Riccardo Balestri
    • 1
  1. 1.Department of Experimental, Diagnostic and Specialty MedicineDivision of DermatologyBolognaItaly

Personalised recommendations